Skip to content

Spyre Therapeutics, Inc.

SYRE· NasdaqCore metricsCIK 1636282

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -3.61%
Market cap
$9.77B
94.97M shares
Filings
823
$0.00
FY 2025
-$96.12M
Q3 2026N/M FY25 yoy
-$105.72M
Q3 2026N/M FY25 yoy
-$157.41M
FY 2024derivedN/M FY24 yoy
-$2.04
Q3 2026N/M FY23 yoy
$82.73M
Q3 2026−4.1% FY25 yoy
$9.77B
—
—
9.3×
—
—

FY2025 figures · derived

Price

$102.89+340.45%+$79.53past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$18.74M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$886,000reported
FY 20222022-12-31$2,329,000reported
FY 20212021-12-31$18,739,000reported
FY 20202020-12-31$0reported
FY 20192019-12-31$0reported
FY 20182018-12-31$3,888,000reported
FY 20172017-12-31$5,205,000reported
FY 20162016-12-31$4,628,000reported

Segments

Products
Revenue by Products, FY2019 to FY2025FY2019FY2020FY2021Development fee and royalty · FY2021 · $6.74MDevelopment Fee · FY2021 · $6.74MLicense · FY2021 · $12.00MFY2022Development fee and royalty · FY2022 · $2.33MDevelopment Fee · FY2022 · $2.33MFY2023Development fee and royalty · FY2023 · $886.00KFY2024FY2025
LineFY2025ShareChange
Development fee and royalty$0.00——
Development Fee———
License———
Total$0.00

From the 10-K filed Feb 19, 2026SYRE

Pharmaceutical preparations

Spyre Therapeutics, Inc. is the 32nd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Spyre Therapeutics, Inc. · CIK 1636282 · Engraved from SEC EDGAR